1. Home
  2. FIHL vs RXRX Comparison

FIHL vs RXRX Comparison

Compare FIHL & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FIHL
  • RXRX
  • Stock Information
  • Founded
  • FIHL 2014
  • RXRX 2013
  • Country
  • FIHL Bermuda
  • RXRX United States
  • Employees
  • FIHL N/A
  • RXRX N/A
  • Industry
  • FIHL
  • RXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FIHL
  • RXRX Health Care
  • Exchange
  • FIHL Nasdaq
  • RXRX Nasdaq
  • Market Cap
  • FIHL 1.8B
  • RXRX 2.1B
  • IPO Year
  • FIHL 2023
  • RXRX 2021
  • Fundamental
  • Price
  • FIHL $18.09
  • RXRX $5.49
  • Analyst Decision
  • FIHL Hold
  • RXRX Buy
  • Analyst Count
  • FIHL 7
  • RXRX 4
  • Target Price
  • FIHL $20.43
  • RXRX $7.25
  • AVG Volume (30 Days)
  • FIHL 506.0K
  • RXRX 33.1M
  • Earning Date
  • FIHL 11-11-2025
  • RXRX 11-05-2025
  • Dividend Yield
  • FIHL 3.31%
  • RXRX N/A
  • EPS Growth
  • FIHL N/A
  • RXRX N/A
  • EPS
  • FIHL N/A
  • RXRX N/A
  • Revenue
  • FIHL $2,607,600,000.00
  • RXRX $64,596,000.00
  • Revenue This Year
  • FIHL $21.24
  • RXRX $24.09
  • Revenue Next Year
  • FIHL $5.01
  • RXRX $20.99
  • P/E Ratio
  • FIHL N/A
  • RXRX N/A
  • Revenue Growth
  • FIHL 21.21
  • RXRX 30.14
  • 52 Week Low
  • FIHL $14.17
  • RXRX $3.79
  • 52 Week High
  • FIHL $21.32
  • RXRX $12.36
  • Technical
  • Relative Strength Index (RSI)
  • FIHL 60.66
  • RXRX 63.90
  • Support Level
  • FIHL $16.96
  • RXRX $4.57
  • Resistance Level
  • FIHL $18.60
  • RXRX $5.00
  • Average True Range (ATR)
  • FIHL 0.50
  • RXRX 0.30
  • MACD
  • FIHL 0.03
  • RXRX 0.10
  • Stochastic Oscillator
  • FIHL 69.09
  • RXRX 81.42

About FIHL Fidelis Insurance Holdings Limited

Fidelis Insurance Holdings Ltd is a specialty insurer that leverages strategic partnerships to offer tailored insurance solutions. The company classifies its business into two segments, Insurance and Reinsurance. A majority of its revenue is generated from the Insurance segment, which comprises a portfolio of property, marine, aviation and aerospace, political risk, violence and terror, energy, cyber, and other insurance risks. The Reinsurance segment consists of an actively managed property reinsurance book, providing reinsurance and a limited amount of retrocession coverage across the world on a proportional or excess-of-loss basis. Geographically, the company derives its key revenue from the United Kingdom, followed by Bermuda and the Republic of Ireland.

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Share on Social Networks: